A US panel voted in favour of wider use of Abbott Laboratories’ rheumatoid arthritis drug, Humira. The drug is already approved for six other conditions and now it has been backed to treat ...

I often say that investing rarely has a dull moment, which is why I find it so fascinating. The beginning of 2025 certainly ...

Winter founded Cambridge Antibody Technology in 1989, which first discovered adalimumab using phage display technology as part of a development partnership with BASF Pharma. After Abbott bought ...

When Abbott Labs spun off AbbVie in 2013, Humira was the new company's cash cow. The autoimmune disease drug ranked as the world's top-selling medication for years. AbbVie used nearly every trick ...

Humira (adalimumab) is an immunosuppressant ... with a decades-long history of yearly increases from when it was still part of Abbott Labs. Investors can probably expect mid- to high-single ...